ReviewSurgery today2025
Maintenance of resection margins in gastrectomy for cancer: simple in procedure, influential in survival-current status and literature review on optimal lengths and positive margins.
Review in Surgery today, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe prognostic significance of the proximal margin length (PML) and positive resection margins (PRMs) in gastric cancer (GC) remains controversial. International guidelines for PML differ widely, reflecting a lack of consensus on optimal surgical margins. While positive RMs are associated with poor survival, their impact varies according to the tumor stage and nodal involvement.
methodsA comprehensive review of the relevant literature was conducted to evaluate guideline recommendations on PML, factors influencing pathological negativity, the prognostic impact of PMLs and PRMs, and treatment strategies for cases with PRMs, including incidence, additional resection, and adjuvant therapy.
resultsA tumor-specific approach is essential for determining the optimal PML. When achieving the recommended PML is challenging, an intraoperative frozen section (IFS) analysis helps to ensure negative margins while minimizing unnecessary resection. PRMs are associated with poor survival, particularly in early stage GC, whereas their impact in advanced-stage GC is often overshadowed by systemic disease progression. Additional resection may benefit the selection of patients with early stage GC; however, its role in advanced-stage GC remains uncertain.
conclusionFurther research should refine surgical decision-making, optimize PML thresholds, and evaluate the role of multimodal treatment strategies, including molecular profiling and intraoperative imaging techniques. Effective management of PRMs requires balancing oncological safety with functional preservation.
Indexed as
Identifiers
40481866What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.